Fundraising Fox

Gene Solutions

Charlottesville, US · Virginia LLC · 1 known investors

Biotech

Founders & leadership

WD
W. Davis Parker, Jr.Executive
BW
Brian WarringtonExecutive
EP
Edward P. ConnellExecutive
SD
Susan D. JonesExecutive
DB
David B. PattesonExecutive

Board

JO
James OuryBoard director

Investors · 1

Mekong CapitalreportedHo Chi Minh City · $5.4M – $30M

Reported raises · per SEC filings

Form D private placements

$6M disclosed across 3 of 4 rounds · 2015–2025

▶$5.3MraisedJun 2024 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David B. PattesonExecutive Officer, Director
  • James OuryDirector
  • Edward P. ConnellExecutive Officer, Director
  • Susan D. JonesExecutive Officer, Director
Offering amount
$5.3M
Amount sold
$5.3M
First sale
Dec 2018
Incorporated
Limited Liability Company, Virginia
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$65KraisedAug 2017 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Edward P. ConnellExecutive Officer, Director
  • Brian WarringtonExecutive Officer, Director
  • W. Davis Parker, Jr.Executive Officer, Director
  • James OuryDirector
  • Susan D. JonesExecutive Officer, Director
  • David B. PattesonExecutive Officer, Director
Offering amount
$250K
Amount sold
$65K
First sale
Aug 2017
Incorporated
Limited Liability Company, Virginia
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$639.8KraisedOct 2015 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • W. Davis Parker, Jr.Executive Officer, Director
  • Brian WarringtonExecutive Officer, Director
  • Edward P. ConnellExecutive Officer, Director
  • James OuryDirector
  • Susan D. JonesExecutive Officer, Director
  • David B. PattesonExecutive Officer, Director
Offering amount
$700K
Amount sold
$639.8K
First sale
Sep 2015
Incorporated
Limited Liability Company, Virginia
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Gene Solutions Raises $100M for Genetic Testing Expansionleadsontrees.com · Nov 2025Gene Solutions Looks to Raise $70 Million to Fund Southeast Asia Expansion - Bloombergbloomberg.com · Mar 2024Gene Solutions secures $21 million to facilitate expansion in Southeast Asiavir.com.vn · Sep 2023

Frequently asked questions

Who are Gene Solutions's investors?
Gene Solutions's investors include Mekong Capital.
How much funding has Gene Solutions raised?
Gene Solutions has disclosed $6M raised across 3 of its 4 known rounds.
Where is Gene Solutions headquartered?
Gene Solutions is headquartered in Charlottesville, US.